Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson's disease.
Pilotto A, Ashton NJ, Lupini A, Battaglio B, Zatti C, Trasciatti C, Gipponi S, Cottini E, Grossi I, Salvi A, de Petro G, Pizzi M, Canale A, Blennow K, Zetterberg H, Padovani A. Pilotto A, et al. Among authors: cottini e. J Neurol. 2024 Dec;271(12):7537-7546. doi: 10.1007/s00415-024-12669-7. Epub 2024 Sep 9. J Neurol. 2024. PMID: 39249107 Free PMC article.
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.
Pilotto A, Imarisio A, Conforti F, Scalvini A, Masciocchi S, Nocivelli S, Turrone R, Gipponi S, Cottini E, Borroni B, Rizzetti MC, Pizzi M, Bonanni L, Sturchio A, Espay AJ, Zetterberg H, Ashton NJ, Hye A, Padovani A. Pilotto A, et al. Among authors: cottini e. Parkinsonism Relat Disord. 2021 Jun;87:41-47. doi: 10.1016/j.parkreldis.2021.04.016. Epub 2021 Apr 27. Parkinsonism Relat Disord. 2021. PMID: 33964785
Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson's Disease.
Imarisio A, Pilotto A, Garrafa E, Conforti F, Masciocchi S, Turrone R, Gipponi S, Cottini E, Rizzetti MC, Porrini V, Gussago C, Pizzi M, Guadagni F, Zetterberg H, Ashton NJ, Hye A, Padovani A. Imarisio A, et al. Among authors: cottini e. Neurodegener Dis. 2021;21(5-6):109-116. doi: 10.1159/000523982. Epub 2022 Mar 14. Neurodegener Dis. 2021. PMID: 35287127
Vascular Risk Factors and Cognition in Parkinson's Disease.
Pilotto A, Turrone R, Liepelt-Scarfone I, Bianchi M, Poli L, Borroni B, Alberici A, Premi E, Formenti A, Bigni B, Cosseddu M, Cottini E, Berg D, Padovani A. Pilotto A, et al. Among authors: cottini e. J Alzheimers Dis. 2016;51(2):563-70. doi: 10.3233/JAD-150610. J Alzheimers Dis. 2016. PMID: 26890741
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, Brambilla L, Caratozzolo S, Cortinovis M, Costa A, Cotti Piccinelli S, Cottini E, Cristillo V, Delrio I, Filosto M, Gamba M, Gazzina S, Gilberti N, Gipponi S, Imarisio A, Invernizzi P, Leggio U, Leonardi M, Liberini P, Locatelli M, Masciocchi S, Poli L, Rao R, Risi B, Rozzini L, Scalvini A, Schiano di Cola F, Spezi R, Vergani V, Volonghi I, Zoppi N, Borroni B, Magoni M, Pezzini A, Padovani A. Benussi A, et al. Among authors: cottini e. Neurology. 2020 Aug 18;95(7):e910-e920. doi: 10.1212/WNL.0000000000009848. Epub 2020 May 22. Neurology. 2020. PMID: 32444493
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Pilotto A, Schiano di Cola F, Premi E, Grasso R, Turrone R, Gipponi S, Scalvini A, Cottini E, Paghera B, Garibotto V, Rizzetti MC, Bonanni L, Borroni B, Morbelli S, Nobili F, Guerra UP, Perani D, Padovani A. Pilotto A, et al. Among authors: cottini e. Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16. Eur J Nucl Med Mol Imaging. 2019. PMID: 31098748
73 results